BREAKING NEWS!: FDA Approves Apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer. Read More.
Go here to learn more or to get a mailed copy.
Home » Archives for March 2019
When faced with a prostate cancer diagnosis, like any cancer diagnosis, the typical reaction is to want to do anything and everything that might cure you of the disease. In...Read More
When we hear the dreaded word cancer, money is not usually the first thing that comes to mind. But if you ask survivors or the families of patients, they will...Read More